Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICOLAS C DEJONG

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1902204803
CMS profile
10727468
Location
OXNARD, CA

General Payments · PY2022–2024

$686.44

  • Reported across 31 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$379.50

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $379.50 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $133.66 7
Novo Nordisk AS $113.43 5
GlaxoSmithKline, LLC. $52.65 2
Lilly USA, LLC $27.85 1
OptiNose US, Inc. $27.20 1
Boehringer Ingelheim Pharmaceuticals, Inc. $24.71 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $49.84 3
PY2023 $257.10 11
PY2024 $379.50 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $21.69 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105421136 CMS
AstraZeneca Pharmaceuticals LP $16.69 04/16/2024 Food and Beverage Undisputed 01/23/2026 1104402933 CMS
AstraZeneca Pharmaceuticals LP $30.10 05/06/2024 Food and Beverage Undisputed 01/23/2026 1104383571 CMS
AstraZeneca Pharmaceuticals LP $13.19 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105574996 CMS
AstraZeneca Pharmaceuticals LP $20.00 08/09/2024 Food and Beverage Undisputed 01/23/2026 1105734295 CMS
AstraZeneca Pharmaceuticals LP $15.10 09/30/2024 Food and Beverage Undisputed 01/23/2026 1105390179 CMS
AstraZeneca Pharmaceuticals LP $16.89 11/26/2024 Food and Beverage Undisputed 01/23/2026 1105474887 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.71 06/10/2024 Food and Beverage Undisputed 01/23/2026 1118225567 CMS
GlaxoSmithKline, LLC. $29.87 03/18/2024 Food and Beverage Undisputed 01/23/2026 1116122816 CMS
GlaxoSmithKline, LLC. $22.78 09/16/2024 Food and Beverage Undisputed 01/23/2026 1116338077 CMS
Lilly USA, LLC $27.85 02/26/2024 Food and Beverage Undisputed 01/23/2026 1135906177 CMS
Novo Nordisk Inc $23.15 02/22/2024 Food and Beverage Undisputed 01/23/2026 1100340634 CMS
Novo Nordisk Inc $24.89 08/23/2024 Food and Beverage Undisputed 01/23/2026 1100353058 CMS
Novo Nordisk Inc $21.67 10/21/2024 Food and Beverage Undisputed 01/23/2026 1100513323 CMS
Novo Nordisk Inc $24.67 11/22/2024 Food and Beverage Undisputed 01/23/2026 1100485087 CMS
Novo Nordisk Inc $19.05 12/20/2024 Food and Beverage Undisputed 01/23/2026 1100560985 CMS
Optinose US, Inc. $27.20 05/13/2024 Food and Beverage Undisputed 01/23/2026 1142192455 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.